Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-06 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.520 | -0.500 | 0.0200 | ||||
REV | 3.270M | -708.000K | -3.978M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
FPRX | Five Prime Therapeutics | 37.99 | 0.05 | 0.13% | 1.8B |
You can purchase shares of Five Prime Therapeutics (NASDAQ: FPRX) through any online brokerage.
Other companies in Five Prime Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Zentalis Pharmaceuticals (NASDAQ:ZNTL) and FibroGen (NASDAQ:FGEN).
The latest price target for Five Prime Therapeutics (NASDAQ: FPRX) was reported by Guggenheim on 2021-03-09. The analyst firm set a price target for 38.00 expecting FPRX to rise to within 12 months (a possible 0.03% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Five Prime Therapeutics (NASDAQ: FPRX) is $37.99 last updated Wed Apr 14 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Five Prime Therapeutics.
There is no upcoming split for Five Prime Therapeutics.